K13 mutations and pfmdr1 copy number variation in Plasmodium falciparum malaria in Myanmar
© 2016 Win et al. Background: Artemisinin-based combination therapy has been first-line treatment for falciparum malaria in Myanmar since 2005. The wide extent of artemisinin resistance in the Greater Mekong sub-region and the presence of mefloquine resistance at the Myanmar-Thailand border raise co...
Saved in:
Main Authors: | Aye A. Win, Mallika Imwong, Myat P. Kyaw, Charles J. Woodrow, Kesinee Chotivanich, Borimas Hanboonkunupakarn, Sasithon Pukrittayakamee |
---|---|
Other Authors: | Institute of Medicine (1) |
Format: | Article |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/40856 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number
by: Ric N. Price, et al.
Published: (2018) -
Assessment of pfmdr1 gene copy number by tandem competitive polymerase chain reaction
by: Ric Price, et al.
Published: (2018) -
Impact of glucose-6-phosphate dehydrogenase deficiency on dengue infection in Myanmar children
by: Win Lai May, et al.
Published: (2020) -
Molecular surveillance of Pfkelch13 and Pfmdr1 mutations in Plasmodium falciparum isolates from southern Thailand
by: Thunchanok Khammanee, et al.
Published: (2020) -
Analysis of anti-malarial resistance markers in pfmdr1 and pfcrt across Southeast Asia in the Tracking Resistance to Artemisinin Collaboration
by: Krongkan Srimuang, et al.
Published: (2018)